- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Apr 23, 2024)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Apr 23, 2024 | T-612-21 | CMC | Sofaweb.com Inc. V. Cozey Inc. (unknown) | Toronto | 30 m |
| Apr 23, 2024 | T-481-23 | DRC | Lola Sheppard, Dba Lateral Office Et Al V. C S Design Inc. Et Al (Copyright) | Montréal | 1 h |
| Apr 23, 2024 | T-206-21 | PTC | Yelda Haber Ve Gã?rsel Yayincilik A.s. V. Glwiz Inc. Et Al. (Copyright) | Toronto | 2 h |
| Apr 24, 2024 | T-1257-22 | CMC | Bell Media Inc Et Al. V. Marshall Macciacchera Et Al (Copyright) | Ottawa | 1 h |
| Apr 24, 2024 | T-1522-21 | CMC | Ljc Apparel Llc C.o.b. Kimes Ranch V. 9277-3068 Quebec Incorporated Et Al (Trade Mark) | Ottawa | 1 h |
| Apr 24, 2024 | T-86-23 | CMC | Guardtek Systems Inc. Et Al. V. Guardteck Security Corp. Et Al. (unknown) | Ottawa | 1 h |
| Apr 24, 2024 | T-489-24 | CMC | Bayer Inc., Bayer Healthcare Llc, Et Al V. Apotex Inc (Patent) | Ottawa | 1 h |
| Apr 25, 2024 | T-95-24 | CMC | Bayer Inc. Et Al. V. Celltrion, Inc. Et Al. (Patent) | Ottawa | 1 h |
| Apr 25, 2024 | T-2276-22 | TMC | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Ottawa | 1 h |
| Apr 25, 2024 | T-2318-22 | TMC | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Ottawa | 1 h |
| Apr 26, 2024 | T-675-24 | CMC | Pfizer Canada Ulc Et Al. V. Glenmark Pharmaceuticals Canada Inc. Et Al. (Patent) | Toronto | 30 m |
| Apr 29, 2024 | T-1831-22 | TMC | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*) | Toronto | 1 h |
| Apr 29, 2024 | T-1842-22 | TMC | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*) | Toronto | 1 h |
| Apr 29, 2024 | T-1856-23 | MST | Louis Vuitton Malletier S.a. Et Al. V. Waleed Bani Torf Et Al. (Trade Mark) | Vancouver | 2 d |
| Apr 29, 2024 | T-1643-17 | PTC | Carry Telecom Inc. V. Ezphone Solution Ltd. Et.al. (Trade Mark) | Toronto | 2 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| May 6, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 10 d |
| May 6, 2024 | T-1750-22 | Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*) | Toronto | 9 d |
| May 23, 2024 | T-1750-22 | Actelion Pharmaceuticals Ltd Et Al. V. Sandoz Canada Inc. (Patent - Selexipag*) | Toronto | 2 d |
| May 27, 2024 | T-1563-22 | Boehringer Ingelheim(canada) Ltd Et Al V. Jamp Pharma Corp. (Patent - Nintedanib*) | Toronto | 2 d |
| May 27, 2024 | T-1831-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*) | Toronto | 20 d |
| May 27, 2024 | T-1842-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*) | Toronto | 20 d |
| Jun 17, 2024 | T-1449-20 | Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent) | Toronto | 10 d |
| Jun 25, 2024 | T-1831-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Empagliflozin*) | Toronto | 3 d |
| Jun 25, 2024 | T-1842-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Sun Pharma Canada Inc. (Patent - Empagliflozin*) | Toronto | 3 d |
| Jul 11, 2024 | T-1449-20 | Proslide Technology, Inc. V. Whitewater West Industries, Ltd. (Patent) | Toronto | 1 d |
| Jul 15, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Jul 15, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Aug 12, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Aug 12, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 10 d |
| Aug 12, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 12, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 10 d |
| Aug 19, 2024 | T-233-23 | Poseidon Llc. V. Canada (the Commissioner Of Patents) (unknown) | Toronto | 2 d |
| Aug 28, 2024 | T-2318-22 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 3 d |
| Aug 28, 2024 | T-2276-22 | Boehringer Ingelheim (canada) Ltd Et Al. V. Jamp Pharma Corporation (Patent - Empagliflozin*) | Toronto | 3 d |
| Aug 29, 2024 | T-2133-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Aug 29, 2024 | T-2139-22 | Gilead Sciences, Inc. Et Al V. Pharmascience Inc. (Patent - Tenofovir*) | Toronto | 2 d |
| Sep 9, 2024 | T-435-22 | Australian Mud Company Pty Ltd Et Al. V. Boart Longyear Group Inc. Et Al. (Patent) | Toronto | 10 d |
| Sep 9, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 8 d |
| Sep 16, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 10 d |
| Sep 16, 2024 | T-86-23 | Guardtek Systems Inc. Et Al. V. Guardteck Security Corp. Et Al. (unknown) | Toronto | 10 d |
| Sep 19, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | Toronto | 7 d |
| Sep 25, 2024 | T-754-22 | Sandvik Mining And Construction Oy And Sandvik Canada Inc. V. Epiroc Canada (Patent) | Toronto | 2 d |
| Oct 2, 2024 | T-2582-22 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Pharmascience Inc. (Patent) | Montréal | 2 d |
| Oct 15, 2024 | T-328-22 | Kerry Group Services International, Ltd. Et Al. V. Florida Food Products, Ll (Patent) | Toronto | 1 d |
| Oct 21, 2024 | T-1471-21 | Ge Renewable Energy Canada Inc V. Canmec Industrial Inc. Et Al. (Copyright) | To be determined (TrialJA) | 10 d |
| Oct 28, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Toronto | 16 d |
| Nov 12, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 10 d |
| Nov 12, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 10 d |
| Nov 25, 2024 | T-641-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc. (Patent - Empagliflozin*) | Ottawa | 3 d |
| Dec 2, 2024 | T-786-21 | Flowchem Llc V. Liquidpower Specialty Products Inc. (Patent) | Toronto | 2 d |
| Dec 2, 2024 | T-1429-21 | Liquidpower Specialty Products Inc. V. Baker Hughes Canada Company Et Al. (Patent) | Toronto | 2 d |
| Dec 2, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | To be determined (TrialJA) | 9 d |
| Dec 18, 2024 | T-1624-17 | Mccain Foods Limited V. J.r. Simplot Company Et Al (Patent) | To be determined (TrialJA) | 2 d |
| Jan 13, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 15 d |
| Jan 20, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 20, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 13 d |
| Jan 27, 2025 | T-1506-20 | Meridian Manufacturing Inc. V. Concept Industries Ltd. (Patent) | Winnipeg | 7 d |
| Feb 3, 2025 | T-1040-23 | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 8 d |
| Feb 10, 2025 | T-841-21 | Adeia Guides, Inc. V. Videotron Ltd. (Patent) | Toronto | 3 d |
| Feb 13, 2025 | T-1094-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 13, 2025 | T-1095-23 | Alexion Pharmaceuticals, Inc. Et Al V. Amgen Canada Inc. (Patent - Eculizumab*) | Toronto | 2 d |
| Feb 20, 2025 | T-1040-23 | Otsuka Pharmaceutical Co. Ltd V. Teva Canada Limited (Patent - Brexpiprazole*) | Toronto | 1 d |
| Mar 3, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 8 d |
| Mar 10, 2025 | T-449-20 | Basf Llc Et Al. V. Agracity Crop & Nutrition Ltd. Et Al. (Trade Mark) | Toronto | 6 d |
| Mar 20, 2025 | T-1039-23 | Emd Serono, A Division Of Emd Inc., Canada Et Al. V. Apotex Inc. (Patent) | Toronto | 1 d |
| Apr 28, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 15 d |
| Apr 28, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 21 d |
| Apr 28, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Apr 28, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 9 d |
| May 12, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 19 d |
| May 12, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 19 d |
| May 15, 2025 | T-1731-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Phamra Corporation (Patent) | Toronto | 1 d |
| May 15, 2025 | T-1730-23 | Otsuka Pharmaceutical Co., Ltd V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| May 26, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 10 d |
| May 26, 2025 | T-1288-18 | Gemak Trust V. Jempak Corporation Et Al (Patent) | Ottawa | 3 d |
| May 26, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 10 d |
| Jun 2, 2025 | T-1184-21 | Adeia Guides, Inc. Et Al. V. Bce Inc. Et Al. (Patent) | Toronto | 3 d |
| Jun 9, 2025 | T-1430-23 | Otsuka Pharmaceutical Co., Ltd V. Teva Canada Limited (Patent) | Toronto | 10 d |
| Jun 11, 2025 | T-1777-23 | Amgen Canada Inc Et Al V. Dr. Reddy's Laboratories Ltd. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 11, 2025 | T-2137-23 | Bayer Inc. Et Al. V. Amgen Canada Inc. (Patent) | Toronto | 2 d |
| Jun 11, 2025 | T-1775-23 | Amgen Canada Inc.et Al. V. Natco Pharma (canada) Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Jun 12, 2025 | T-732-22 | Pharmascience Inc. V. Janssen Inc. Et Al. (PMNOC - Section 8 - Abiraterone*) | Toronto | 1 d |
| Jun 23, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 16 d |
| Jun 23, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 14 d |
| Jun 23, 2025 | T-2013-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co. Ltd. (Patent) | Toronto | 14 d |
| Jul 16, 2025 | T-2011-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co., Ltd (Patent) | Toronto | 2 d |
| Jul 16, 2025 | T-2013-23 | Alexion Pharmaceuticals Inc. Et Al. V Samsung Bioepis Co. Ltd. (Patent) | Toronto | 2 d |
| Jul 22, 2025 | T-1939-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Jul 22, 2025 | T-1940-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Pharmascience Inc. (Patent) | Ottawa | 3 d |
| Aug 11, 2025 | T-2251-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent) | Toronto | 15 d |
| Aug 11, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 8 d |
| Aug 25, 2025 | T-2145-23 | Otsuka Pharmaceutical Co., Ltd V Pharmascience Inc. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 9 d |
| Sep 2, 2025 | T-2251-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Dr. Reddy's Laboratories Ltd. (Patent) | Toronto | 2 d |
| Sep 2, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Toronto | 12 d |
| Sep 15, 2025 | T-1737-23 | Otsuka Pharmaceutical Co., Ltd. V. Jamp Pharma Corporation (Patent) | Toronto | 1 d |
| Sep 22, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 22, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 8 d |
| Sep 25, 2025 | T-2751-23 | Boehringer Ingelheim (canada) Ltd. Et Al. V. Apotex Inc (Patent) | Ottawa | 2 d |
| Oct 6, 2025 | T-47-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 6, 2025 | T-48-24 | Janssen Inc. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 2 d |
| Oct 27, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Oct 27, 2025 | T-932-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Glenmark Pharmaceuticals Ca. Inc (Patent) | Toronto | 8 d |
| Nov 12, 2025 | T-156-24 | Viiv Healthcare Company Et Al. V. Pharmascience Inc. (Patent) | Toronto | 2 d |
| Nov 12, 2025 | T-932-23 | Boehringer Ingelheim (canada) Ltd. Et Al V. Glenmark Pharmaceuticals Ca. Inc (Patent) | Toronto | 2 d |
| Nov 17, 2025 | T-2148-23 | Outsuka Pharmaceutical Co. Ltd. V. Pharmascience Inc. (Patent) | Toronto | 10 d |
| Jan 19, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 10 d |
| Feb 5, 2026 | T-1336-23 | Boehringer Ingelheim (canada Ltd.) Et Al. V. Auro Pharma Inc. (Patent - Nintedanib*) | Toronto | 2 d |
| Feb 16, 2026 | T-1584-23 | Amgen Canada Inc. V. Alexion Pharmaceuticals, Inc. (Patent) | Toronto | 10 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| May 2, 2024 | T-173-23 | Randy Williams V. Music And Entertainment Rights Licensing Independent Netwo | Copyright Infringement [Applications] | Edmonton | 2 d |
| May 6, 2024 | T-2642-23 | Canadian Energy Services L.p. V. Commissioner Of Patents Et Al | Patent - Appeal of a Decision of Commissioner | Toronto | 3 h |
| May 7, 2024 | T-1881-23 | Jody Lance Et Al. V. Minister Of Health | S. 18.1 Application for Judicial Review | Ottawa | 1 d |
| May 7, 2024 | T-189-19 | Preventous Collaborative Health V. Canada (minister Of Health) | S. 18.1 Application for Judicial Review | Calgary | 1 d |
| May 7, 2024 | T-190-19 | Provital Health V. Canada (minister Of Health) | S. 18.1 Application for Judicial Review | Calgary | 1 d |
| May 7, 2024 | T-191-19 | Copeman Healthcare Centre V. Canada (minister Of Health) | S. 18.1 Application for Judicial Review | Calgary | 1 d |
| May 27, 2024 | T-44-24 | Red Maple Manufacturing Inc. V. Red Maple Bio Inc. | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 1 h |
| Jun 6, 2024 | T-1895-23 | Smart And Biggar Llp V. Canadian Tire Corporation, Ltd | Trade Mark Infringement | Toronto | 1 d |
| Jun 10, 2024 | T-654-22 | Giuseppe De Luca V. Geox S.p.a. | Trade Mark Expungement | Montréal | 3 h |
| Jun 17, 2024 | T-1369-23 | Emd Serono Et Al V. The Minister Of Health - Cladribine* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jun 18, 2024 | T-2144-23 | T. Rowe Price Group, Inc. V. Glidepath Technologies Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1 d |
| Jun 18, 2024 | T-2728-23 | Bayer Inc V. Amgen Canada Inc. Et Al. - Aflibercept* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| Jul 10, 2024 | T-901-22 | C-tow Marine Assistance Ltd. V. Sea Tow Services International, Inc. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 1.3 d |
| Jul 23, 2024 | T-1706-23 | 2k4 Inc. O/a Indican Pictures V. Indiecan Entertainment Inc. | Trade Mark - Passing Off | Ottawa | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| Apr 9, 2024 | A-203-22 | Abbvie Corporation Et Al V. Minister Of Health Et Al - Adalimumab* | Appeal (S.27 - Final) - Others | Toronto |
| Apr 10, 2024 | A-21-23 | Janssen Inc. V. Agc Et Al | Appeal (S.27 - Final) - Others | Toronto |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.